ArticleEBioMedicine2016

Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment.

Shaveta Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.